Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_assertion type Assertion NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_head.
- NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_assertion description "[The objective of the study was to describe the antitumoral efficacy and toxicity of temozolomide in patients with aggressive pituitary tumors or carcinomas and evaluate the possible prognostic value of MGMT promoter methylation and protein expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_provenance.
- NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_assertion evidence source_evidence_literature NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_provenance.
- NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_assertion SIO_000772 20660056 NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_provenance.
- NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_assertion wasDerivedFrom befree-2016 NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_provenance.
- NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_assertion wasGeneratedBy ECO_0000203 NP828305.RAC9ckDpQh204oMoYgpkAQLFY0up9jCU13zWxBjbksZsM130_provenance.